Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Aptuit

Aptuit is a pharmaceutical services company that delivers early to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Aptuit
Via Alessandro Fleming 4, 37135 Verona (VR), Italy
+39 045 8218111
Contact Aptuit
Website

 Latest Content from PMHub 

Lucid Group announces the appointment of a new Legal and Compliance manager

Press Releases | November 27, 2019 | Lucid Group Communications Limited

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

Press Releases | November 27, 2019 | Lucid Group Communications Limited

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

White Papers and Resources | November 27, 2019 | OPEN Health

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Bedrock’s on fire for Wellbeing Week

Press Releases | November 26, 2019 | Bedrock Healthcare Communications

Bedrock creates a positive working environment to enable individuals and our business to thrive.

WHITE PAPER: Patient nonadherence – the $637bn paradox

White Papers and Resources | November 25, 2019 | IGNIFI

What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you.

Spotlight interview: 15 minutes on insights and market research in pharma

White Papers and Resources | November 21, 2019 | OPEN Health

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

Early diagnosis underpins NHS cancer strategy

White Papers and Resources | November 20, 2019 | Wilmington Healthcare

Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan

Launch Excellence 2020

White Papers and Resources | November 20, 2019 | Blue Latitude Health

In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch...

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

White Papers and Resources | November 20, 2019 | OPEN Health

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...

Antibiotic resistance: The silent pandemic

Press Releases | November 18, 2019 | Porterhouse Medical Group

Porterhouse is proud to support World Antibiotic Awareness Week. Our article aims to improve awareness of one of the biggest threats to global health today: antibiotic resistance.